Previously (9), we examined the Id profile of the antibody response of BALB/c mice to immune complexes formed in antigen excess. The complexes were prepared using the TEPC-15 myeloma protein and the PC-containing polysaccharide antigen (PnC). 1 The antibody response to this antigen in BALB/c mice is dominated by the T15 family of Id that are expressed on the TEPC-15 myeloma protein (10, 11) . Our previous results (9) showed that the TEPC-15/ PnC complexes readily induced an antigen-specific PFC response that was equal to the response induced by free antigen; however, the Id profile of the response to the complex was more restricted than that of the response to the free antigen (9) . Thus, the proportion of Id PFC (as determined by plaque-inhibition with the AB1-2 (11)anti-T15 mAb) was greater and more variable in individual mice immunized with PnC vs. those injected with TEPC-15/PnC complexes.
The above results were obtained using BALB/c mice, a strain in which the response to PnC is dominated by a major or recurrent Id. This study was undertaken to examine the response to TEPC-15/PnC complexes using mouse strains in which the T15 (AB1-2) Id is not dominant. The results show that the response to TEPC-15/PnC complexes is under genetic control, and that responsiveness to the complex correlates with the level of T 15 (AB 1-2) Id produced in response to immunization with free antigen (PnC). The results suggest that the antigen-specific response to immune complexes is Id-restricted and, therefore, that the recognition of Id is important in regulating the immune response.
Materials and Methods
Animals. Female mice of the following strains were purchased from The Jackson Laboratories, Bar Harbor, ME: BALB/cByJ, C3H/HeJ, C3H.SW, and C3H.OH, SEC/1ReJ, A/J, AKR/J, CE/J, C58/J, and (BALB/cByJ X C3H/HeJ)F~. BALB.B and BALB.K mice were obtained from the Animal Resources Facility of Jewish Hospital of St. Louis. CB-20 mice were the generous gift of Dr. Jan Cerny of the University of Texas Medical branch at Galveston. All mice were used between the age of 8 and 14 wk.
Antigens. PnC was extracted from Streptococcus pneumoniae R36a as described by Anderson and McCarty (12) . The concentration of PnC was based on the weight of dialyzed, lyophilized material. Sheep and burro red blood cells (RBC) were obtained from Cleveland Scientific (Cleveland, OH).
mAb and Myeloma Proteins. The AB1-2 (anti-T15) hybridoma cell line was generously provided by Dr. John Kearney, University of Alabama, Birmingham, AL. The AB1-2 mAb and the TEPC-15 myeloma protein were partially purified from ascites fluid as described elsewhere (13) .
Plaque-forming Cell Assay. A microscope slide modification of the Jerne-Nordin hemolytic plaque assay was used (14) . The PnC antigen spontaneously binds to RBC in the absence of phosphates. Thus, the RBC target cells were coated with PnC by incubating 1 vol of burro RBC (washed three times in 0.85% saline) with 4 vol of PnC (0. I mg/ml in 0.85% saline) at 37°C for 1 h. The coated RBC were washed twice with saline, then resuspended to a 15% suspension in HBSS (Gibco Laboratories, Grand Island, NY). For the plaque assay, the following ingredients were added to tubes containing 0.2 ml of molten 0.5% agarose (Sea Plaque; FMC Maine Colloids, Rockland, ME) at 37°C: RBC, 0.04 ml of a 15% suspension; complement, 0.04 ml of a 1:3 dilution of guinea pig serum (preadsorbed with the target RBC); and spleen cells, 0.1 ml (various cell numbers). For plaque-inhibition assays, AB1-2 mAb was added at a final concentration of 1:300. The contents of the tubes were poured onto glass slides (precoated with a 0.1% solution of Abbreviations used in this paper: GAMIgM-AP, goat anti-mouse IgM-alkaline phosphatase; PnC, cell wall polysaccharide extracted from Streptococcus pneumoniae R36a. agarose) and incubated at 37°C for 2 h in a sealed, humid chamber. The number of plaques was scored with the aid of a magnifying glass. The results are expressed as the geometric mean of the number of PFC/spleen from 3-5 mice/group, assayed in duplicate.
Assay for Serum Antibody and Id. The serum IgM antibody response specific for PnC was measured by an ELISA as previously described (I 5). The serum concentration of IgM antibodies expressing the T15 Id defined by the AB1-2 mAb was determined by ELISA as follows: Polyvinyl chloride 96-well microtiter plates (Dynatech Laboratories, Alexandria, VA) were coated with 50 ~1 of a 10 #g/ml solution (in 0.05 M Tris and 0.15 M saline, pH 9.5) of the IgG mAb, AB1-2 (17), which had been prepared from ascites fluid by ammonium sulfate precipitation. After 4 h at 37°C, the plates were blocked with 0.05% gelatin in PBS, then washed three times with 0.15 M saline with 0.05% Tween 20 (polyoxyethylene sorbitan monolaurate; Sigma Chemical Co., St. Louis, MO). Serial fivefold dilutions of serum, in PBS-0.05% Tween with 0.05% gelatin (PBS-T), were made in consecutive wells of the coated plates in a final volume of 0. I ml, and the plates were incubated overnight at 4°C. A T15 Id + IgM mAb (41-H11) specific for PnC that was prepared in this laboratory was used as a standard. After the second incubation period, the plates were washed three times with saline-Tween and then 50 #1 ofa 1:1,000 dilution of alkaline phosphatase-conjugated goat anti-mouse IgM (GAMIgM-AP) (Southern Biotechnology Associates, Birmingham, AL) was added to each well. After an overnight incubation at 4°C, the plates were washed three times with saline-Tween and then 50 ul of phosphatase substrate (p-nitrophenyl phosphate, 1 mg/ml in Tris-saline with 1 mM magnesium chloride, pH 9.5) was added to each well and incubated for 30 min at room temperature. The reaction was stopped by adding 50 #1 of 3 M NaOH to each well. The optical density at 405 nm in each well was determined using an MR580 MicroELISA Auto Reader (Dynatech Laboratories), and antibody concentrations were determined relative to the standard using a computer program as previously described (15) .
Preparation oflmmune Complexes.
Initially, complexes were prepared at various ratios to determine the equivalence zone. The complexes were incubated at 37°C for 30 min, and then at 4 °C overnight or until used. The complexes were centrifuged at ~800 g, and the supernatants were removed and tested for the presence of excess antigen or antibody. Excess antibody was detected by ELISA as described elsewhere (I 5), and excess antigen was detected by ELISA as follows: plates were coated as described above with the IgA myeloma protein, TEPC-15, and then samples to be tested for PnC were titrated in consecutive wells of the coated plates. An lgM anti-PnC mAb (41-H11) was then added at 1 t~g/well. Finally, GAMIgM-AP was added to each well, and the reaction was developed with p-nitrophenyl phosphate. The antigen concentration of the unknown samples was determined relative to a known standard.
Once the equivalence zone bad been determined, complexes were prepared in antigen excess by adding a 10-fold excess of PnC to a standard amount of TEPC-15. Before use, the complexes were washed twice with 0.85% saline, an aliquot was dissolved in 0.1 N NaOH, and the protein concentration was determined as described previously (13) . The amount of complex used was based on the concentration of protein in the complex.
Results
The results shown in Table I show that the injection of TEPC-15/PnC complexes (formed in antigen excess) into BALB/c mice elicits a PnC-specific antibody response that is comparable to that induced with antigen alone. On the other band, immunization of C3H mice with TEPC-15/PnC complexes resulted in a weak response that was 10-fold less than the response to PnC alone. The results also show that the PnC-specific response of BALB/c mice is dominated by the T15 (AB1-2) Id, whereas the response of C3H mice is AB1-2-negative, confirming the results of others (11) . Thus, the response to the complex appears to be genetically restricted.
Since the restriction appears to be mediated by the antibody (TEPC-15) used Mice from each strain were injected intraperitoneally with either 1 tag of PnC or with various concentrations of TEPC-15/PnC complexes as indicated. 5 d later, the number of direct PFC was determined using PnC-coated burro RBC as target cells. The results are expressed as the geometric mean of the number of PFC/spleen with the standard error factor in parentheses. The percentage of PFC secreting the T15 idiotope defined by the AB1-2 mAb was determined by plaque inhibition. to form the complex, we reasoned that the response might be allotype restricted.
Thus, CB-20 mice (which are congenic with BALB/c at the lgh locus) were tested for responsiveness to PnC and to TEPC-15/PnC complexes. The results (Table  II) demonstrate that the CB-20 mice responded almost as well to the complex as they did to free antigen. Thus, the response to the complex does not appear to be allotype-restricted. Interestingly, even though CB-20 mice are Igh b, their response to both PnC and TEPC-15/PnC complexes is dominated by the T15 (AB1-2) Id.
In further experiments, we wished to determine whether responsiveness to the complexes was controlled by I-region genes in the H-2 complex. Thus, we used two H-2 congenic strains on the C3H background, C3H.SW and C3H-OH. C3H mice are H-2 k, whereas the C3H.SW strain is H-2 b, and the I-region of the C3H-OH strain is of the d haplotype, the same as that of BALB/c mice, The results from Table III 
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• . (BALB/c X C3H)F1 mice gave an intermediate response to the complex. The C58 strain appears to be an exception, since it is Igh a, yet tends to be a low responder; however the response of individual mice from this strain was variable, with some mice yielding a relatively high response, which was T15 (AB1-2)-positive (data not shown). The SEC strain also appears to be an exception since it has been classified as Igh j (20) ; however, the allotype of this strain remains uncertain, since previous studies by Herzenberg et al. (21) indicated that the SEC strain is Igh h.
When the results from Fig. 1 were analyzed in more detail, it became apparent that the high-responder strains (to immunization with TEPC-15/PnC complexes) expressed high levels of T 15 (AB1-2) Id in their response to PnC, whereas lowresponder strains produced relatively Tow leveTs of TI 5 in their response to PnC. Indeed, as shown in Fig. 2 , there is a very strong correlation between responsiveness to the TEPC-15/PnC complex and the level of T15 Id produced in the response of each strain to PnC. These results suggest that the genetic factors that control T 15 Id expression also control responsiveness to the TEPC-15/PnC complex.
The results thus far are consistent with the concept that the response to TEPC-15/PnC complexes is Id-restricted. This suggests that BALB/c mice should be low responders to complexes formed using a T15-antibody. To address this question, we prepared a T15-PnC-specific mAb from C3H mice (which are low responders to the TEPC-15/PnC complex). This antibody (79-14G6) was used to form complexes with PnC to test for immunogenicity in BALB/c mice. The C3H antibody (79-14G6) is IgM; therefore, control complexes were prepared using a BALB/c IgM antibody (41-H11) rather than using TEPC-15, which is IgA. As shown in Table IV , BALB/c mice gave a good PnC-specific antibody response (8,290 PFC/spleen) to complexes formed with the BALB/c antibody, whereas they gave a low response (1,036 PFC/speen) to complexes formed with the C3H antibody. There are no reported allelic differences between BALB/c Table I. and C3H IgM antibodies (both are Igh-6a); therefore, these results support our conclusion that the response to certain immune complexes is Id-restricted.
Discussion
The results of these studies indicate that the antigen-specific response of mice to TEPC-15/PnC immune complexes is genetically controlled, i.e., the response of certain strains to the complex is 10-folcl less than their response to free antigen. Since the TEPC-15 myeloma was derived from BALB/c mice, and since BALB/c but not C3H mice were responders to the complex, we attempted to determine whether responsiveness was allotype-restricted by using CB-20 mice, which are congenic with BALB/c mice at the Igh locus. The results showed that CB-20 (Igh b) mice responded as well or better than BALB/c (Igh ~) mice. Thus, responsiveness to the complex does not appear to be restricted to strains expressing the same allotype as BALB/c. Furthermore, the antibody used to form the complex (TEPC-15) is IgA, whereas the response that we measured is IgM. Taken together, the results suggest that responsiveness to the TEPC-15/PnC complex is not determined by immunoglobulin heavy chain constant region gene products.
The response to many antigens is controlled by genes located in the I region of the MHC (16) (17) (18) . Therefore, determination of whether the I region controlled the response to TEPC-15/PnC complexes seemed reasonable. Thus, we determined the response of H-2 congenic CBH mice to PnC and to TEPC-15/PnC complexes. The results showed that both C3H.SW (H-2 b) and C3H-OH (which has the d haplotype in the I region) are similar to C3H (H-2 k) mice in that they are low responders to the complex. In spite of sharing the same I region genes, C3H-OH mice are low responders whereas BALB/c mice are high responders to the TEPC-15/PnC complexes. Thus, the I region does not appear to control responsiveness to the complex.
In a reciprocal experiment, we tested the response of BALB.B and BALB.K mice (which are congenic with BALB/c at the H-2 complex) for their response to PnC and TEPC-15/PnC complexes. Interestingly, the results showed that BALB.K mice gave a response to free PnC that was -10-fold higher than the response of BALB.B mice, whereas BALB/c mice yielded an intermediate response. Thus, the antibody response to PnC appears to be under Ir gene control. Nevertheless, in each strain, the response to the complex was approximately the same as the response to the free antigen, indicating that H-2 genes were not controlling responsiveness to the immune complex. The antigen used in these studies (PnC) is a soluble extract from S. pneumoniae R36a; it differs from a vaccine prepared from whole bacteria, which is highly immunogenic in BALB.B mice (J. Cerny, personal communication).
Responsiveness to the antigen/antibody complex appears to correlate with the ability of a mouse strain to produce high levels of antibody that expresses the same idiotype as that used to form the complex. Thus, strains such as BALB/c and CB-20, which express high levels of the T15 (AB 1-2) Id are high responders to TEPC-15/PnC complexes, whereas strains such as C3H, C3H.SW, and C3H-OH (which express low levels of the T15 [AB1-2] Id) are low responders to the complex. When the results from 13 strains were examined (Fig. 2) , there was a very strong correlation between the level of response to the complex and the level of T 15 (AB 1-2) Id produced in response to PnC. These results suggest that the same genetic elements that control the expression of the T15 (AB1-2) Id may also control the response to TEPC-15/PnC complexes.
Claflin (19) has shown that mice from a large variety of strains express the T15 Id, as defined by an A/J (mouse) anti-T15 sera; however, three strains C3H/HeJ, CBA/J, and PL/J (which are all Igh j) were shown to express low levels of this Id. In contrast, the SEC strain, which has been classified as Igh j (20) , was found to express high levels of the T15 idiotype (19) , suggesting that the expression of T15 is not controlled by allotype-linked genes. However, classification of the SEC strain as Igh j is questionable, since Herzenberg et al. (21) had previously determined this strain to be Igh h. In other studies, Sher and Cohn (22) examined the strain distribution of the S107 Id (which is identical to the T15 Id examined herein) using a conventional anti-Id antiserum prepared in CE/J mice. Their results suggested that the expression of the S 107 Id is controlled by multiple factors, including Igh-linked genes and genes of the H-2 complex. Our current results, found using the anti-T15 mAb AB1-2 (11), favor the conclusion that the expression of the T15 Id is controlled by ailotype-linked genes. Thus, responsiveness to the complex (which is correlated with the expression of the T 15 Id) also appears to be controlled by allotype-linked genes.
The apparent requirement for Id recognition in the response to TEPC-15/PnC complexes leads us to suggest that the response is dependent on Id-specific helper cells. Indeed, we have preliminary results demonstrating that athymic BALB/c nude mice are low responders to TEPC-15 PnC complexes (M. Caulfield and D. Isaak, unpublished observation), indicating that responsiveness to the complex is T-dependent. The putative Id-specific helper T cells could interact directly with B cells via the Id expressed on surface immunoglobulin molecules, resulting in the selective stimulation of an Id + response. Alternatively, the immune complex could serve as a bridge to link Id-specific T cells with antigen-specific B cells. In the second case, the response to the complex could be composed of a mixture of Id ÷ and Id-antibodies. Indeed, we have observed (Fig. 1 ) that the response of several strains to TEPC-15/PnC complexes is not completely dominated by the T15 (AB1-2) Id, suggesting that T15-B cells are being triggered. This second possibility suggests that Id-specific helper T ceils could stimulate Id-B cells when the two cells were linked by the appropriate antigen/antibody bridge. This would be analogous to the interaction of carrier-specific helper T cells with hapten-specific B cells via a hapten-carrier conjugate (23) in which both Id + and Idantibodies would be induced. In support of the above argument, Klaus (24) has presented evidence for the activation ofanti-Id antibody through the cooperation of antigen-specific T cells and Id-specific B cells mediated through immune complexes. Furthermore, we previously showed (9) that the T15 (AB1-2) Id is exposed in the TEPC-15/PnC complexes, since anti-Id antibody binds to the complexes. Presumably, the Id (in the complex) could also be recognized by Idspecific helper T cells.
The results shown here may have some relevance to the phenomenon of Id matching in the response to PC-KLH described by Bottomly et al. (25, 26) . These investigators showed that carrier-primed T cells could induce an Iddominated response in recipient mice only if both the T cell donors and the recipient mice were Id +. These results were interpreted to suggest the existence of a helper T cell population that recognizes both antigen and Id. Our results suggest a mechanism whereby two separate populations of helper T ceils, one carrier-specific and the other Id-specific, could be responsible for the Id-matching phenomenon. Thus, we suggest that the PC-KLH antigen (employed by Bottomly et al.) could form complexes with Id + antibody when injected into Id + recipients, thereby allowing Id-specific helper cells to interact with Id + B cells and carrierspecific T cells. Id-recipient mice could not form Id + immune complexes, and therefore would not trigger an Id-dominated response. Support for this notion was provided by Woodland and Cantor (27) , who showed that Id-specific helper T cells were required (in addition to carrier-specific helper cells) for optimal production of antibody to hapten-carrier conjugates.
Our finding that the antigen-specific response to the TEPC-15/PnC complex correlates with the relative dominance of the T15 (AB1-2) Id suggests that preexisting Id-specific regulatory mechanisms control the response to the immune complex. Thus, presentation of antigen in the context of Id (i.e., in the form of an immune complex) restricts the response to the antigen. Therefore, our results strongly indicate that the recognition of self-Id is important in controlling the immune response. This information adds further support to the network hypothesis (2).
Summary
The primary antigen-specific antibody response of various strains of mice to TEPC-15/PnC immune complexes has been examined. We found that both BALB/c and C3H mice were good responders to the PnC antigen; however, C3H mice were low responders, whereas BALB/c mice were high responders to the TEPC-15/PnC complexeS. Using congenic strains on the C3H and BALB/c background, we have shown that the response to the complexes is not restricted by gene products of the H-2 complex or by the Igh (allotype) locus. However, responsiveness may be controlled by genes linked to the Igh locus, since we have shown that strains that are Igh ), IgU, and Ighfare low responders, whereas strains that are Igh ~, Igh b, and Igh e are high responders to the immune complex.
Moreover, responsiveness correlates with the expression of the T15 Id as measured using the anti-T15 monoclonal antibody, AB1-2. Thus, strains such as BALB/c, BALB.B, BALB.K, and CB-20, which express high levels ofT15 (AB1-2) Id in their PFC response to PnC are relatively bigh responders to TEPC-15/PnC complexes, whereas C3H, C3H.SW, and C3H-OH, whicb express low levels of the T15 (AB1-2) Id, are low responders to the complexes. Finally, we found that BALB/c mice are high responders to complexes formed with TI5 + antibodies, whereas they are low responders to complexes formed using T15-antibodies. The results suggest that the antigen-specific response to these immune complexes is Id-restricted.
